[1]
P. Vishwakarma, A. Kumar, M. Sharma, M. Garg, and K. Saxena, “Histone deacetylase inhibitors: pharmacotherapeutic implications as epigenetic modifier”, Int J Basic Clin Pharmacol, vol. 3, no. 1, pp. 27–36, Jan. 2017.